BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15570919)

  • 1. [Combination chemotherapy for gastric cancer including LV/5-FU].
    Sasaki T; Maeda Y; Kandaba-shi K; Ono M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
    Sasaki T; Maeda Y; Kobayashi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of leucovorin and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1001-8. PubMed ID: 7611750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal administration in combination chemotherapy with 5-fluorouracil and cisplatin for gastric cancer].
    Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1763-9. PubMed ID: 8937486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
    Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
    J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fifth-line chemotherapy for metastatic gastric cancer--a case responding to modified FOLFOX 6].
    Sagawa T; Sato Y; Takayama T; Kuroda H; Hirakawa M; Abe S; Iyama S; Sakamaki S; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1467-71. PubMed ID: 17876148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
    Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
    Uemura N; Yamada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
    Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
    Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB
    Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
    J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical modulation--the historical background].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):941-5. PubMed ID: 1626949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of levofolinate calcium and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):315-22. PubMed ID: 10700909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
    J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
    Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY; Kwon HC; Seo BG; Kim SH; Kim JS; Kim HJ
    Acta Oncol; 2007; 46(3):336-41. PubMed ID: 17450469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.